Phase 1 ER+/HER2- Breast Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.

Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer Stage IV+1 more

Forward Pharmaceuticals Co., Ltd.99 enrolled22 locationsNCT06064812

Recruiting

Phase 1Phase 2

Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients

Advanced ER+/HER2- Breast Cancer

Qilu Pharmaceutical Co., Ltd.300 enrolled1 locationNCT07235176